July 7, 2016

Compliance: Avoiding the CAPA Trap


It is no secret that the development and implementation of effective, streamlined Corrective and Preventive Action (CAPA) processes for addressing noncompliance is a critical aspect of maintaining compliance within Pharmaceutical GMP operations.

Navigating the nuances of developing effective CAPAs for GCP operations, however, can prove to be difficult for pharmaceutical companies of all sizes. While the processes and procedures involved in GMP tend to be easily defined and measureable, GCP procedures are often more nebulous and difficult to pin down with reliable metrics.

Fill out the form below to get our white paper.

[Form id="17"]